Skip to main content
. 2018 May 10;2018(5):CD012069. doi: 10.1002/14651858.CD012069.pub2

Houmann 2011.

Trial name or title Individualised methylphenidate therapy based on pharmacogenetics: focus on carboxylesterase1 (CES1)
Methods Multicentre study on CES1 genotype response in ADHD children
Participants 200 drug‐naïve children with ADHD
Interventions Methylphenidate, type not specified
Outcomes CES1 genotype response, adverse reaction, discontinuation of treatment, treatment failure
Starting date 2011, otherwise not specified
Contact information Tine Bodil Houmann
Email: Tine.Houmann@regionh.dk
Notes Personal email correspondence with the first author in September 2013 revealed the study is ongoing (Houmann 2013 [pers comm])